In accordance with 5 CFR 1320, the information collection is approved for three years.
Inventory as of this Action
Requested
Previously Approved
10/31/2018
36 Months From Approved
1,180
0
0
458
0
0
0
0
0
The NRC is requesting a one-time information collection that will be solicited in an FRN. The FRN will have specific I-131 patient release questions associated with: (1) Existing Web sites that the responders believe provide access to clear and consistent patient information about I-131 treatment processes and procedures; (2) information the responders believe represent best practices used in making informed decisions on releasing I 131 patients and stand alone or supplemental voluntary patient/licensee guidance acknowledgment forms, if available; (3) an existing set of guidelines that the responder developed or received that provides instructions to released patients; and (4) an existing guidance brochure that the responder believes would be acceptable for nationwide distribution. The responses will form the basis for patient release guidance products developed in response to the NRC's April 28, 2014, Staff Requirements-COMAMMâ14â 0001/COMWDMâ14â0001-"Background and Proposed Direction to NRC Staff to Verify Assumptions Made Concerning Patient Release Guidance." The Commission, based on information from patients and patient advocacy groups, questioned the availability of clear, consistent, patient friendly and timely patient release information and directed the staff to work with a wide variety of stakeholders when developing new guidance products. This information collection effort was developed to gain input from as many stakeholders as possible. The NRC solicitation in the Federal Register is to obtain existing information from a variety of stakeholders.
The Nuclear Regulatory Commission is requesting a one-time information collection solicited by a FRN that will include specific sodium iodide I-131 patient release questions associated with four topics. NRC expects responders will spend 457.5 hours responding. Information obtained from the responses will form the basis for patient release guidance products developed in response to the NRC's April 28, 2014 the Staff Requirements â COMAMM-14-0001/COMWDM-14-0001 â "Background and Proposed Direction to the NRC Staff to Verify Assumptions Made Concerning Patient Release Guidance."
$127,503
No
No
No
No
No
Uncollected
Donna Howe 301 415-7848
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
2015-15391.pdf
Rev FINAL SUPPORTING STATEMENT Iodine 131 Sept 18 2015 highlight HOWE.docx
NRC Request for Sodium Iodide I-131 Treatment and Patient Release Information